Most cited papers in Systemic Sclerosis and Related Diseases
What are the most cited papers in Systemic Sclerosis and Related Diseases?
The most cited paper in Systemic Sclerosis and Related Diseases is "APACHE II-A Severity of Disease Classification System" (William A. Knaus, Elizabeth A. Draper, Douglas P. Wagner et al., 1986), with 13,426 citations. Next come "Evaluation of Diagnostic Criteria for Ankylosing Spondylitis" (5,762) and "Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study" (5,057).
Showing 50 of 98 papers. Every paper with more than 747 citations is listed.
| # | Paper | ||
|---|---|---|---|
| 1 | APACHE II-A Severity of Disease Classification System William A. Knaus, Elizabeth A. Draper, Douglas P. Wagner et al. · Critical Care Medicine | Aug 1986 | 13,426 |
| 2 | Evaluation of Diagnostic Criteria for Ankylosing Spondylitis Sjef van der Linden, Hans A. Valkenburg, A. Cats · Arthritis & Rheumatism | Apr 1984 | 5,762 |
| 3 | Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study Hana Štorkánová, Sabína Oreská, Maja Špiritović et al. · Scientific Reports | 7 Jan 2021 | 5,057 |
| 4 | Preliminary criteria for the classification of systemic sclerosis (scleroderma) Alfonse T. Masi · Arthritis & Rheumatism | May 1980 | 4,957 |
| 5 | Cellular and molecular mechanisms of fibrosis Thomas A. Wynn · The Journal of Pathology | 27 Dec 2007 | 4,557 |
| 6 | An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias William David Travis et al. · American Journal of Respiratory and Critical Care Medicine | Sep 2013 | 4,352 |
| 7 | A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis Talmadge E. King, Williamson Z. Bradford, Socorro Castro-Bernardini et al. · New England Journal of Medicine | 18 May 2014 | 4,051 |
| 8 | Scleroderma (systemic sclerosis): classification, subsets and pathogenesis E. Carwile LeRoy, Casilda G. Black, Raúl Fleischmajer et al. | 6 Dec 2001 | 3,976 |
| 9 | Mechanisms of fibrosis: therapeutic translation for fibrotic disease Thomas A. Wynn, Thirumalai R. Ramalingam · Nature Medicine | Jul 2012 | 3,589 |
| 10 | 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative Frank H J van den Hoogen et al. · Arthritis & Rheumatism | 3 Oct 2013 | 3,458 |
| 11 | SYSTEMIC LUPUS ERYTHEMATOSUS DISEASE ACTIVITY INDEX Dafna D. Gladman, Dominique Ibañez, Murray B. Urowitz · Elsevier eBooks | 2007 | 2,977 |
| 12 | Wegener Granulomatosis: An Analysis of 158 Patients Gary Stuart Hoffman, Gail S. Kerr, Randi Y. Leavitt et al. · Annals of Internal Medicine | 15 Mar 1992 | 2,881 |
| 13 | Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline Ganesh Raghu et al. · American Journal of Respiratory and Critical Care Medicine | 29 Apr 2022 | 2,844 |
| 14 | Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis John H. Stone et al. · New England Journal of Medicine | 14 Jul 2010 | 2,775 |
| 15 | 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus Martin Aringer et al. · Arthritis & Rheumatology | 6 Aug 2019 | 2,644 |
| 16 | Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus Melissa R. Arbuckle, Micah T. McClain, Mark V. Rubertone et al. · New England Journal of Medicine | 15 Oct 2003 | 2,612 |
| 17 | The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus Dafna D. Gladman et al. · Arthritis & Rheumatism | Mar 1996 | 2,609 |
| 18 | Nintedanib in Progressive Fibrosing Interstitial Lung Diseases Kevin R. Flaherty, Athol Umfrey Wells, Vincent Cottin et al. · New England Journal of Medicine | 29 Sep 2019 | 2,440 |
| 19 | Chronic graft-versus-host syndrome in man Howard M. Shulman, Keith M. Sullivan, Paul L. Weiden et al. · The American Journal of Medicine | Aug 1980 | 2,436 |
| 20 | Systemic sclerosis Christopher P. Denton, Dinesh Khanna · The Lancet | 13 Apr 2017 | 2,230 |
| 21 | Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA) Gordon C. Sharp, William S. Irvin, Eng M. Tan et al. · The American Journal of Medicine | Feb 1972 | 1,855 |
| 22 | Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis Rachel Bronwen Jones, Jan Willem Cohen Tervaert, Thomas Häuser et al. · New England Journal of Medicine | 14 Jul 2010 | 1,759 |
| 23 | Pathologic Classification of Diabetic Nephropathy Thijs W. Cohen Tervaert, Antien L. Mooyaart, Kerstin Amann et al. · Journal of the American Society of Nephrology | 18 Feb 2010 | 1,724 |
| 24 | Epidemiology and Estimated Population Burden of Selected Autoimmune Diseases in the United States Denise L. Jacobson, Stephen J. Gange, Noel R. Rose et al. · Clinical Immunology and Immunopathology | Sep 1997 | 1,686 |
| 25 | Cyclophosphamide versus Placebo in Scleroderma Lung Disease Donald P. Tashkin et al. · New England Journal of Medicine | 21 Jun 2006 | 1,683 |
| 26 | The classification of glomerulonephritis in systemic lupus erythematosus revisited Jan J. Weening et al. · Kidney International | 8 Jan 2004 | 1,678 |
| 27 | Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease Oliver Distler, Kristin B. Highland, Martina Gahlemann et al. · New England Journal of Medicine | 20 May 2019 | 1,667 |
| 28 | Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer Thomas R. Cox, Janine Terra Erler · Disease Models & Mechanisms | 15 Feb 2011 | 1,609 |
| 29 | Changes in causes of death in systemic sclerosis, 1972–2002 V. Steen, Thomas A. Medsger · Annals of the Rheumatic Diseases | Mar 2007 | 1,540 |
| 30 | The Management of Thrombosis in the Antiphospholipid-Antibody Syndrome Munther A. Khamashta, María José Cuadrado, Fedza Mujic et al. · New England Journal of Medicine | 13 Apr 1995 | 1,475 |
| 31 | Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases Thomas A. Wynn · Journal of Clinical Investigation | Mar 2007 | 1,474 |
| 32 | Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database A. J. Tyndall et al. · Annals of the Rheumatic Diseases | 15 Jun 2010 | 1,461 |
| 33 | Prevalence and Correlates of Accelerated Atherosclerosis in Systemic Lupus Erythematosus Mary J. Roman, Beth‐Ann Shanker, Adrienne Davis et al. · New England Journal of Medicine | 17 Dec 2003 | 1,430 |
| 34 | Criteria for the classification of early systemic sclerosis. E. Carwile LeRoy, Thomas A. Medsger · PubMed | Jul 2001 | 1,403 |
| 35 | Morbidity and Mortality in Systemic Lupus Erythematosus During a 10-Year Period Ricard Cervera, Munther A. Khamashta, Josep Font et al. · Medicine | Sep 2003 | 1,392 |
| 36 | Scleroderma Armando Gabrielli, Enrico Vittorio Avvedimento, Thomas M. Krieg · New England Journal of Medicine | 6 May 2009 | 1,391 |
| 37 | Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies Richard Watts, Suzanne E. Lane, Thomas Hanslik et al. · Annals of the Rheumatic Diseases | 10 Aug 2006 | 1,375 |
| 38 | A Multidimensional Index and Staging System for Idiopathic Pulmonary Fibrosis Brett Ley, Christopher J. Ryerson, Eric Vittinghoff et al. · Annals of Internal Medicine | 15 May 2012 | 1,350 |
| 39 | Incidence and Prevalence of Idiopathic Pulmonary Fibrosis Ganesh Raghu, Derek A. Weycker, John Edelsberg et al. · American Journal of Respiratory and Critical Care Medicine | 30 Jun 2006 | 1,326 |
| 40 | Transforming growth factor–β in tissue fibrosis Nikolaos G. Frangogiannis · The Journal of Experimental Medicine | 25 Dec 2019 | 1,322 |
| 41 | Idiopathic Pulmonary Fibrosis: Clinical Relevance of Pathologic Classification Anna-Luise A. Katzenstein, Jeffrey L. Myers · American Journal of Respiratory and Critical Care Medicine | Apr 1998 | 1,270 |
| 42 | Modification and validation of the Birmingham Vasculitis Activity Score (version 3) Chetan B. Mukhtyar, R Lee, Denise Scott Brown et al. · Annals of the Rheumatic Diseases | 3 Dec 2008 | 1,253 |
| 43 | Interstitial Lung Disease in Systemic Sclerosis Nicole S L Goh, Sujal R. Desai, Srihari Veeraraghavan et al. · American Journal of Respiratory and Critical Care Medicine | 27 Mar 2008 | 1,209 |
| 44 | Exosomes/microvesicles as a mechanism of cell-to-cell communication Giovanni Camussi, Maria Chiara Deregibus, Stefania Bruno et al. · Kidney International | 11 Aug 2010 | 1,189 |
| 45 | The natural history of multiple sclerosis:a geographically based study David A. Cottrell, Marcelo Kremenchutzky, George P. Rice et al. · Brain | Apr 1999 | 1,170 |
| 46 | Systemic sclerosis: a prototypic multisystem fibrotic disorder John Varga, David Abraham · Journal of Clinical Investigation | Mar 2007 | 1,166 |
| 47 | Update of EULAR recommendations for the treatment of systemic sclerosis Otylia Kowal‐Bielecka et al. · Annals of the Rheumatic Diseases | 10 Nov 2016 | 1,129 |
| 48 | The prevalence of MS in the United States Mitchell Taylor Wallin, William J. Culpepper, Jonathan D. Campbell et al. · Neurology | 15 Feb 2019 | 1,128 |
| 49 | Pathologic observations in systemic sclerosis (scleroderma) William D’Angelo, James F. Fries, Alfonse T. Masi et al. · The American Journal of Medicine | Mar 1969 | 1,123 |
| 50 | An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features Aryeh Fischer, Katerina M. Antoniou, Kevin M. Brown et al. · European Respiratory Journal | 9 Jul 2015 | 1,111 |
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for a field when OpenAlex files it under one of the field's topics; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.